Unlike the well-established role of pTau-217 in AD, where levels track a protracted neurodegenerative course, TBI elicits an acute and heterogeneous pathological cascade that may cause distinct tau phosphorylation and release patterns. Here, MAPT is linked to Alzheimer disease.